QGEN

QIAGEN N.V.

NYSE · Biological Products, (No Diagnostic Substances) · Inc. P7 · CIK 0001015820
$37.06 -0.96% $7.6B
Vol
Market Cap$7.6B
Cap SizeMid Cap
Analyst ConsensusHold (43%)
Exchange NYSE·Sector Biological Products, (No Diagnostic Substances)·Inc. P7·CIK 0001015820·Prev Close $37.42

Recent Activity

Jun 12, 2026 short_volume
Short Volume: QGEN — 65.5% short (0.4M / 0.7M)
Short: 428,375 | Exempt: 2,056 | TRF Vol: 654,425 | Short Ratio: 65.5% | Off-exchange volume (dark p

Price Targets

$43.82 +18.2% upside Buy
Current $37.06 Low $36.00 Median $43.00 High $59.00 14 analysts
$36.00 $59.00

Analyst Ratings

Hold43% buy · 23 analysts
5Strong Buy
5Buy
13Hold
0Sell
0Strong Sell
Recent Analyst Actions
DateFirmActionRating
May 18, 2026 Stifel MAINTAIN Hold → Hold
May 7, 2026 TD Cowen MAINTAIN Hold → Hold
Apr 29, 2026 JP Morgan MAINTAIN Overweight → Overweight
Apr 29, 2026 Citigroup MAINTAIN Neutral → Neutral
Apr 29, 2026 Barclays MAINTAIN Equal-Weight → Equal-Weight

Earnings Estimates

PeriodEPS Est.RangeGrowth#
Current Q $0.60 ▼ -1.3% $0.60 — $0.62 -5% YoY 9
Next Q $0.63 ▼ -1.2% $0.61 — $0.65 -2% YoY 9
Current FY $2.44 $2.38 — $2.54 3% YoY 14
Next FY $2.64 $2.57 — $2.76 8% YoY 14

No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.

No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.

No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Current analyst consensus: Hold (43% buy). Based on 23 analysts: 5 strong buy, 5 buy, 13 hold, 0 sell, 0 strong sell.

Analyst Price Targets

$43.82 mean target +18.2% upside Buy (2.07)
$36.00 Low $59.00 High
MetricValue
Current Price$37.06
Target Low$36.00
Target Mean$43.82
Target Median$43.00
Target High$59.00
# Analysts14
RecommendationBuy (2.07)

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
2026-06-30
$0.60 $0.60 $0.62 -4.7% -1.3% 0↑ 9↓ $0.5B -0.9% 9
Next Q
2026-09-30
$0.63 $0.61 $0.65 -1.5% -1.2% 0↑ 9↓ $0.6B 3.6% 9
Current FY
2026-12-31
$2.44 $2.38 $2.54 2.6% +0.1% 0↑ 6↓ $2.2B 3.2% 14
Next FY
2027-12-31
$2.64 $2.57 $2.76 8.0% -0.5% 0↑ 12↓ $2.3B 5.4% 14

Current Quarter EPS Revision History

TimepointEPS EstimateChange
Current$0.602
7d ago$0.603-0.001
30d ago$0.610-0.008
60d ago$0.622-0.020
90d ago$0.622-0.020
7 analyst firms have rated this stock: 2 upgrades, 2 downgrades, 0 initiations.

Individual Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
May 18, 2026 Stifel MAINTAIN Hold Hold
May 7, 2026 TD Cowen MAINTAIN Hold Hold
Apr 29, 2026 JP Morgan MAINTAIN Overweight Overweight
Apr 29, 2026 Citigroup MAINTAIN Neutral Neutral
Apr 29, 2026 Barclays MAINTAIN Equal-Weight Equal-Weight
Apr 29, 2026 Baird UPGRADE Neutral Outperform
Apr 14, 2026 Barclays DOWNGRADE Overweight Equal-Weight
Mar 13, 2026 Deutsche Bank UPGRADE Hold Buy
Feb 6, 2026 JP Morgan MAINTAIN Overweight Overweight
Feb 6, 2026 Citigroup MAINTAIN Neutral Neutral
Feb 6, 2026 Stifel MAINTAIN Hold Hold
Jan 22, 2026 Deutsche Bank DOWNGRADE Buy Hold
Dec 15, 2025 Barclays MAINTAIN Overweight Overweight

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Jun 1, 202655130043%
May 1, 202656130046%
Apr 1, 202647130046%
Mar 1, 202646140042%
Feb 1, 202646140042%
Jan 1, 202647130046%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

Jun 12, 2026
short_volume
Short Volume: QGEN — 65.5% short (0.4M / 0.7M)
Short: 428,375 | Exempt: 2,056 | TRF Vol: 654,425 | Short Ratio: 65.5% | Off-exchange volume (dark pool + OTC)
Jun 10, 2026
short_volume
Short Volume: QGEN — 75.7% short (0.7M / 1.0M)
Short: 744,536 | Exempt: 3,417 | TRF Vol: 984,006 | Short Ratio: 75.7% | Off-exchange volume (dark pool + OTC)
May 18, 2026
short_volume
Short Volume: QGEN — 57.6% short (0.6M / 1.1M)
Short: 639,307 | Exempt: 16,701 | TRF Vol: 1,110,357 | Short Ratio: 57.6% | Off-exchange volume (dark pool + OTC)
May 18, 2026
dark_pool
Dark Pool: QGEN — 2.3M shares, 37,448 trades
Week starting 2026-05-18. Total ATS volume: 2,255,330 shares across 37,448 trades.
May 15, 2026
short_volume
Short Volume: QGEN — 55.9% short (0.4M / 0.7M)
Short: 390,501 | Exempt: 450 | TRF Vol: 698,253 | Short Ratio: 55.9% | Off-exchange volume (dark pool + OTC)
May 14, 2026
short_volume
Short Volume: QGEN — 61.6% short (0.9M / 1.5M)
Short: 915,209 | Exempt: 2,778 | TRF Vol: 1,485,356 | Short Ratio: 61.6% | Off-exchange volume (dark pool + OTC)
May 11, 2026
dark_pool
Dark Pool: QGEN — 3.5M shares, 57,068 trades
Week starting 2026-05-11. Total ATS volume: 3,499,412 shares across 57,068 trades.
May 6, 2026
earnings_calendar
QGEN Q1 2026 Earnings After Market Close — 2026-05-06
May 5, 2026
earnings_calendar
QGEN Q1 2026 Earnings After Market Close — 2026-05-05
May 4, 2026
earnings_calendar
QGEN Q1 2026 Earnings After Market Close — 2026-05-04
May 4, 2026
dark_pool
Dark Pool: QGEN — 2.3M shares, 41,025 trades
Week starting 2026-05-04. Total ATS volume: 2,258,738 shares across 41,025 trades.
Apr 30, 2026
short_interest
FTD: QGEN — 52,799 shares ($1.8M) failed to deliver
Settlement: 20260430, Price: $33.61, FTD Value: $1,774,574.39, QIAGEN NV SYNTHETIC SH REPURCH
Apr 29, 2026
short_interest
FTD: QGEN — 39,651 shares ($1.3M) failed to deliver
Settlement: 20260429, Price: $34.02, FTD Value: $1,348,927.02, QIAGEN NV SYNTHETIC SH REPURCH
Apr 28, 2026
short_interest
FTD: QGEN — 18,139 shares ($0.7M) failed to deliver
Settlement: 20260428, Price: $38.09, FTD Value: $690,914.51, QIAGEN NV SYNTHETIC SH REPURCH
Apr 27, 2026
dark_pool
Dark Pool: QGEN — 6.4M shares, 65,800 trades
Week starting 2026-04-27. Total ATS volume: 6,388,527 shares across 65,800 trades.